Ayala Pharmaceuticals (NASDAQ:ADXS) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Wednesday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH restated a neutral rating on shares of Ayala Pharmaceuticals in a research report on Thursday, November 16th. Check Out Our Latest Report […]
More Stories
US Lawmakers Head to Denmark as Trump Presses Bid to Take Over Greenland
By Guy Birchall A bipartisan group of U.S. lawmakers arrived in Denmark on Jan. 16 for talks with Danish and...
Is Selling Sunset Season 10 Renewing? Release Date, Cast, and Controversy
Selling Sunset season 9 started where it had ended in season 8. The conflict between the cast members continues. Especially...
Google’s Fast Pair Protocol Might Lead to Millions of Hacked Bluetooth Devices!
Belgium’s KU Leuven University’s researchers revealed a disturbing Bluetooth vulnerability called ‘WhisperPair’ affecting hundreds of millions of wireless headphones, earbuds,...
How Rich Is Antony Blinken? Net Worth, Income & Properties (2026)
Antony Blinken, a government official and a senior diplomat of America, served as the 71st Secretary of the United States....
Market Players React to Trump Ban on Institutional Investment in Homes
By Mary Prenon President Donald Trump recently proposed several policies to tackle the severe housing affordability problem facing Americans, including...
Venezuela’s Machado Gifts Trump Her Nobel Peace Prize Medal
By Emel Akan WASHINGTON—U.S. President Donald Trump hosted Venezuelan opposition leader María Corina Machado for a lunch meeting at the...